quality-risk pat 
Camargo
NOVEMBER 15, 2021
Recent advances in manufacturing technology and process analytical technology (PAT), along with regulatory initiatives, have encouraged the industry to consider replacing batch manufacturing with CM. One major advantage is the ability to reduce batch losses by diverting materials not meeting quality standards through the use of PAT.
Roots Analysis
AUGUST 30, 2023
This is expected to help in the creation of a uniform process, which is capable of decreasing the deviation in quality of each batch. Other key benefits of digital biomanufacturing include improved efficiency, higher product yield, better product quality, data integrity, reduced manual intervention and limited risk of contamination.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 29, 2022
In times of accelerated process design, pharma companies must drop manual workflows that risk clerical errors and data integrity violations. Digital batch execution management, electronic lab notebooks, and factory dashboards can remove risk from these error-prone processes.
pharmaphorum
DECEMBER 16, 2022
Instead, take your children out for a fun day at the theme park, volunteer at the local soup kitchen, spend quality time with your parents, have friends over for New Year’s Eve, or enjoy dinner with your spouse. Appreciate strong partners.
Pharmaceutical Technology
JUNE 26, 2022
This minimizes downstream risks, helps to determine a suitable synthetic route for scale-up, and facilitates an easier transition into the formulation development phase. PAT enables us to make use of software and artificial intelligence (AI) as a predictive control tool. Important considerations for drug substance development.
Pharmaceutical Technology
APRIL 12, 2023
Evidence suggests that API manufacturing is gaining in complexity, as well as sophistication, and therefore adding to the risk profile of drug development. The ingredients used in these drugs are high potency, even at small doses, and pose a risk to both human health and cross-contamination with other drugs in a manufacturing environment.
Pharmacy Checkers
MAY 1, 2020
Now, the lead scholar and policy wonk on the online pharmacy testing is Roger Bate, PhD, an economist affiliated with the American Enterprise Institute who specializes in drug quality and public health. Bayer’s “pat-on-the back” press release did not mention where Resochin is made. It’s made in Pakistan. pharmacies are imported.
Expert insights. Personalized for you.
187 
Let's personalize your content